« Back Urologic Oncology: Seminars and Original Investigations

Article in Press

To the Editor: Response to Barlow et al, Urol Oncol 2010

Published online 07 September 2010 Corrected Proof

References 

  1. Barlow LJ, Seager CM, Benson MC, et al. Novel intravesical therapies for non-muscle-invasive bladder cancer refractory to BCG. Urol Oncol. 2010;28:108–111
  2. Steinberg G, Bahnson R, Brosman S, et al. Efficacy and safety of valrubicin for the treatment of bacillus Calmette-Guerin refractory carcinoma in situ of the bladder (The Valrubicin Study Group). J Urol. 2000;163:761–767

PII: S1078-1439(10)00167-5

doi: 10.1016/j.urolonc.2010.06.008

« Back Urologic Oncology: Seminars and Original Investigations

Article in Press

Article Tools